← Leaderboards
Anthony R French
Washington University
$6,642,370
Attributed
$7,566,011
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $760K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,566,011 · 5
By mechanism
R01$5,266,056 · 2
T32$1,847,282 · 2
K08$452,673 · 1
Top collaborators
- David Alan Hunstad4 shared
- Deborah J Lenschow3 shared
Most similar at Washington University
Same institution · by research overlap
- Wayne M. Yokoyama$86,270,787
- Daved H Fremont$19,011,013
- Robert C. Orchard$4,280,460
- Jeffrey J Bednarski$3,929,996
- Lee Ratner$26,026,037
Others in their field
Top investigators on “Natural Killer Cells”
- Barton F Haynes · Duke University$112,979,211
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Craig B Thompson · Sloan-Kettering Inst Can Research$42,638,329
- Selwyn M Vickers · University Of Alabama At Birmingham$41,029,054
- James C. Paulson · Scripps Research Institute$39,353,775
Research focus
Natural Killer CellsCellsPathogenLigandsMediatingReceptorIn VivoViralT-LymphocyteIn VitroHost DefenseCytokineInfectionResistanceLymphocyteResponseProductionImmune SystemPlayCytomegalovirus InfectionsNk Cell ActivationMurid Herpesvirus 1Receptor ActivationVirus
Grant awards (25)
Immunobiology of the Rheumatic Diseases$375,953
T32 · FY2023 · AR
Immunobiology of the Rheumatic Diseases$423,566
T32 · FY2022 · AR
Pediatric Infectious Diseases and Immunity Training Program$152,944
T32 · FY2022 · AI
Immunobiology of the Rheumatic Diseases$378,399
T32 · FY2021 · AR
Pediatric Infectious Diseases and Immunity Training Program$160,966
T32 · FY2021 · AI
Pediatric Infectious Diseases and Immunity Training Program$181,194
T32 · FY2020 · AI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$381,250
R01 · FY2019 · AI · contact PI
Pediatric Infectious Diseases and Immunity Training Program$174,260
T32 · FY2019 · AI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$381,250
R01 · FY2018 · AI · contact PI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$381,250
R01 · FY2017 · AI · contact PI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$381,250
R01 · FY2016 · AI · contact PI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$381,250
R01 · FY2015 · AI · contact PI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$350,092
R01 · FY2013 · AI · contact PI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$372,438
R01 · FY2012 · AI · contact PI
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS$372,438
R01 · FY2011 · AI · contact PI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$372,438
R01 · FY2011 · AI · contact PI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$376,200
R01 · FY2010 · AI · contact PI
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS$376,200
R01 · FY2010 · AI · contact PI
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS$380,000
R01 · FY2009 · AI · contact PI
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION$380,000
R01 · FY2009 · AI · contact PI
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS$380,000
R01 · FY2008 · AI · contact PI
Natural Killer Cell Mediated Control of Vaccinia Virus$120,088
K08 · FY2007 · AI · contact PI
Natural Killer Cell Mediated Control of Vaccinia Virus$117,220
K08 · FY2006 · AI · contact PI
Natural Killer Cell Mediated Control of Vaccinia Virus$114,435
K08 · FY2005 · AI
Natural Killer Cell Mediated Control of Vaccinia Virus$100,930
K08 · FY2004 · AI